Showing posts with label Ranbaxy Labs. Show all posts
Showing posts with label Ranbaxy Labs. Show all posts

Few Volatile Stocks good for Short Term

>> Saturday, July 18, 2009

The Vulture Play
These stocks have fallen like there’s no bottom. But the levels at which they are trading offer huge opportunities.

Strategy: Buy on rumours and sell on news.

Suzlon: Debt is high and so are the receivables. But Tulsi Tanti is willing to dilute his stake and meet commitments. If US President Barack Obama backs energy generation from green sources, Suzlon’s 5 MW wind turbines will be hot. The stock has gained nearly 300 percent since the time it fell to Rs. 35.

Ranbaxy: The last 12 months have been bad. Sales are down, research hasn’t paid off and US FDA is after it for manufacturing lapses. But the new Japanese owner Daiichi Sankyo has had great successes in research and working with the FDA. Expect them to put Ranbaxy back on an even keel.

NIIT: As IT crashed so did the IT trainer. Its stock fell 85 percent to Rs. 14. But it is moving beyond IT and is training professionals for banking jobs. The amount spent on education doubled in the last five years and NIIT grew twice as fast, quadrupling its top line. The stock has recovered to half its 52-week high.

Wockhardt: Its core business is in fine fettle. Its problems are foreign loan repayments and derivative losses. Banks are taking over the company operations and Habil Khorakiwala has put some businesses on the block to pay off debtors. Wockhardt’s strong cash flow should return it to good health in two years.

Hindalco: The acquisition of Novelis tripled Hindalco’s sales but caused an 11 percent decline in net profits. But aluminum prices are rising and credit is beginning to flow. Hindalco’s nine-month profits look nice. It now has the space to fix Novelis. Tricky but not impossible.

Risk: This one’s clearly a high risk strategy. There could be serious heart ache before the gains come.


Source : Forbes India.

Read the full post...

Market outlook and Intraday tips for 3rd Feb.

>> Tuesday, February 3, 2009

US markets ended mixed.
Europe was trading in red. Asia has opened mixed.
I expect Indian markets to open flat to negative.
Markets may remain volatile throught the day.

The support for the Sensex is 9034-8940-8868 and the resistance to the up move is at 9232

Nifty: (2767) the support for the Nifty is at 2705 and the resistance to the up move is at 2820


Day Trading Ideas


DLF

Buy above 156 for targets of 160 and 163

Sell below 149 for targets of 144 and 141


Hindalco

Buy above 47.90 for targets of 49.10 and 50.50

Sell below 44.10 for targets of 43.25 and 42.50


Ranbaxy Labs

Buy above 214 for targets of 218 and 221

Sell below 209 for targets of 207 and 203


Now get NIFTY EDO technicals (Autogenerated) Every Day Here.


Free SMS Updates subscribe - Click here


Happy Investing !

Read the full post...

Q3 Earnings Update!

>> Thursday, January 22, 2009

My 2 cents on what to expect of the earnigs being announced today.

Reliance Industries - A big question mark on Q3, but whatever the management has to say today will define how the indexes move. It is most weighted stock in Senex & Nifty and is bound to pull its weight

Ranbaxy Laboratories Ltd - Good scrip to look out for especially after
Japan company merger. I think Healthcare is recession proof.

Bharti Airtel - Is expected meet estimates for Q3. But Outlook will be worrying due to saturation in current markets. Newer market penetration will require capital expenditure which will be hard to come by in Q4.

Idea Cellular - I am a seller of this Telecom company. With too much competion and a price war looming, margins will be affected, it will be difficult to survice without a merger with one of the bigger companies or even 2 smaller partners working together.

Kotak Mahindra - One of the better investment and financial banks. They seem to have limited exposure to any toxic assets. I will be a buyer of this stock at these levels. Earnigs should be encouraging.


-- About Me --

I am Tushar Makhija, co-founder of stockezy.com and like contributing to IndianMoneyPlus.com. I like the open minded approach of the authors. Looking to participate more. If you guys are interested in meeting many such like-minded bloggers and people interested in investing, check out stockezy.com

Read the full post...

Indian Companies very attractive for Foreign Mergers.

>> Monday, November 17, 2008

The India Growth Story is one which is well known all around the world. The current global crisis and stock market meltdown has made good-growth oriented Indian Companies very very cheap with respect to valuations. Some are trading at up to 30-40% discounted share prices in comparison with 2007. 

So is the time come for Mergers and foreign companies dishing out dollars to take good amount of percentage stakes in India Inc. ? Well we have seen the following mergers already:

  1. Ranbaxy Labs
  2. Tata Teleservices. 
More than ever now is right time for cash rich foreign companies to increase the stakes in India. From a ROI perspective the whole  world is sold on the fact that India is the land of opportunity, with an educated work force, a surging middle-class which propels consumer growth, the future is surely bright. 

Also India's companies are well managed, have solid balance-sheets and good products on offer. Today what is hampering growth is lack of liquidity, slow lending by banks, higher interest rates and looming global crisis. Also the lower stock price makes the deal lucrative as the dollar is stronger than the rupee.

To top it all up, selling equity to generate capital is not such a bad idea, look at the deal with DoCoMo and Tata Tele, with the money also comes technical collaboration and experience which all adds value to the company and augurs well for growth. 

Telecom sector, Banking, Airlines can all see some M&A action in the coming days.
Source: - stockezy.com

Read the full post...